EpiPen patent revoked in Europe
marrio31 / iStockphoto.com
The US Food and Drug Administration (FDA) yesterday granted Teva approval for the first generic version of EpiPen (epinephrine), an autoinjector pen used for the emergency treatment of allergic reactions.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
FDA, Food and Drug Administration, generics, EpiPen, allergic reactions, approval, Scott Gottlieb, competition, Mylan